Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frans Van de Werf

Showing results (1-10 of 388) with videos related to

Pageof 39
Sort By:
Nature Reviews. Cardiology|July 27, 2010
Acute coronary syndromes: Transport for PCI versus fibrinolysis--long-term data scrutinizedFrans Van de Werf
European Heart Journal|September 1, 2010
Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery diseaseFrans Van de Werf
Circulation|December 23, 2009
Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndromeFrans Van de Werf
European Heart Journal|July 16, 2014
The history of coronary reperfusionFrans Van de Werf
European Heart Journal|January 16, 2015
European Society of Cardiology European Affairs: bringing science to policy-makersFrans Van de Werf
European Heart Journal|December 17, 2008
The European Heart Journal: parting thoughts after 6 years of editorshipFrans Van de Werf
Kardiologia Polska|April 11, 2018
Reperfusion treatment in acute myocardial infarction in elderly patientsFrans Van de Werf
Circulation|May 3, 2017
Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy?Frans Van de Werf
Circulation|January 9, 2008
Spotlight: Frans Van de Werf, MD, PhD. Interview by Richard HoeyFrans Van de Werf
Timely Topics in Medicine. Cardiovascular Diseases|April 9, 2008
Current challenges and directions in antithrombotic therapyFrans Van de Werf
Pageof 39

Showing results (1-10 of 388) with videos related to

Sort By:
Pageof 39
Nature Reviews. Cardiology|July 27, 2010
Acute coronary syndromes: Transport for PCI versus fibrinolysis--long-term data scrutinizedFrans Van de Werf
European Heart Journal|September 1, 2010
Thrombin receptor antagonists may become an important antiplatelet therapy for coronary artery diseaseFrans Van de Werf
Circulation|December 23, 2009
Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndromeFrans Van de Werf
European Heart Journal|July 16, 2014
The history of coronary reperfusionFrans Van de Werf
European Heart Journal|January 16, 2015
European Society of Cardiology European Affairs: bringing science to policy-makersFrans Van de Werf
European Heart Journal|December 17, 2008
The European Heart Journal: parting thoughts after 6 years of editorshipFrans Van de Werf
Kardiologia Polska|April 11, 2018
Reperfusion treatment in acute myocardial infarction in elderly patientsFrans Van de Werf
Circulation|May 3, 2017
Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy?Frans Van de Werf
Circulation|January 9, 2008
Spotlight: Frans Van de Werf, MD, PhD. Interview by Richard HoeyFrans Van de Werf
Timely Topics in Medicine. Cardiovascular Diseases|April 9, 2008
Current challenges and directions in antithrombotic therapyFrans Van de Werf
Pageof 39